Wednesday, September 2, 2026 · Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days
Neutral Normal choppiness · VIX 15.4
The NASDAQ 100 shows a bifurcated tape: a broad swath of constituents are down double digits over the past 30 days (semis, software, industrials), while a smaller cohort of mega-cap tech, biotech and energy names are holding near 52-week highs with sustained 5-day and 30-day gains. Oil-supply risk from renewed US-Iran tension is lifting energy names, and AI-driven memory/storage demand continues to power select semiconductor strength.
Which of today's picks to actually take, and at what size, given what you are already holding. Each pick's own Suggested Allocation sizes it in isolation; this table applies the portfolio limits — at most 20 open positions and 60% of the portfolio committed in total. Run with --capital 25000 to see these sizes as order amounts rather than percentages.
| Rank | Stock | Action | Size | Entry → Target | Notes |
|---|---|---|---|---|---|
| #1 | ALNY | SKIP | — | $263.48 → $277.74 stop $237.13 |
Position cap reached — 111 of 20 slots in use. |
| #2 | CRWD | SKIP | — | $203.16 → $214.62 stop $181.02 |
Position cap reached — 111 of 20 slots in use. |
| #3 | TMUS | SKIP | — | $187.01 → $196.86 stop $172.80 |
Position cap reached — 111 of 20 slots in use. |
Already open: AMP (to Sep 3), RJF (to Sep 4), NVDA (to Sep 5), SWK (to Sep 6), WAT (to Sep 9), LLY (to Sep 10), DRI (to Sep 11), DXCM (to Sep 11), BDX (to Sep 12), BLK (to Sep 12), EXPD (to Sep 13), FDX (to Sep 13) … and 99 more. Symbols you already hold were excluded from this run's candidates rather than re-picked.
Position-sizing guidance only — half-Kelly per pick, bounded by the limits above. Not personal investment advice.
Alnylam is a biotech company that develops RNA-based drugs. Its shares have climbed nearly 20% over the past month and are still accelerating, comfortably outpacing the broader tech market. The key risk is that biotech stocks are inherently volatile and can swing sharply on drug-trial or regulatory news that's impossible to predict.
Why the AI likes it
What could go wrong
Calibrated probability: 66% (raw model estimate: 62%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
CrowdStrike sells cybersecurity software that protects companies' computers and cloud systems from hackers. It just reported its best quarter ever, with record new business growth, and management explicitly raised its full-year growth outlook — a clear, direct sign of confidence. The main risk is the company's CEO has been selling shares steadily for weeks, and the stock isn't cheap, so any stumble could hit it hard.
Why the AI likes it
What could go wrong
Calibrated probability: 66% (raw model estimate: 66%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
T-Mobile is one of the largest US wireless carriers. Its stock has been in a tight, tightening trading range that often precedes a breakout move, and the trend is modestly positive. The main concern is that trading volume isn't fully backing up the recent price gains, which is a caution sign that the move could fade rather than continue.
Why the AI likes it
What could go wrong
Calibrated probability: 66% (raw model estimate: 66%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by October 2, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.
Step-by-Step Action Plan
Position Sizing by Conviction Tier
Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.
| Agents Agreeing | What It Means | Max Allocation Per Pick |
|---|---|---|
| 5/5 | Highest conviction — all five independent analytical checks passed | Up to 10% |
| 4/5 | Very high conviction — four of five independent checks aligned | Up to 8% |
| 3/5 | High conviction — three agents independently agreed | Up to 6% |
| 2/5 | Moderate conviction — two agents independently agreed | Up to 4% |
| 1 Agent | Speculative — solo pick, admitted only at Very High confidence | Up to 2% |
The Three Exit Rules
A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.
Scout scanned 101 NASDAQ 100 constituents and short-listed 23 candidates for deep analysis by the five analysts. Here is what happened to each one.
Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.
Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).
Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.
Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.
Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.
Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.